PTC Therapeutics, Inc. (PTCT)
USD 43.4
(-7.14%)
USD 43.4
(-7.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.9 Billion USD | 11.58% |
| 2022 | 1.7 Billion USD | -11.99% |
| 2021 | 1.93 Billion USD | -12.24% |
| 2020 | 2.2 Billion USD | 36.0% |
| 2019 | 1.62 Billion USD | 45.08% |
| 2018 | 1.11 Billion USD | 185.77% |
| 2017 | 391.65 Million USD | 45.41% |
| 2016 | 269.34 Million USD | -26.82% |
| 2015 | 368.04 Million USD | 10.45% |
| 2014 | 333.21 Million USD | 119.36% |
| 2013 | 151.9 Million USD | 1062.02% |
| 2012 | 13.07 Million USD | -70.39% |
| 2011 | 44.14 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.78 Billion USD | -5.97% |
| 2024 Q2 | 1.91 Billion USD | 7.08% |
| 2023 Q2 | 1.33 Billion USD | -16.83% |
| 2023 Q4 | 1.9 Billion USD | 51.06% |
| 2023 FY | 1.9 Billion USD | 11.58% |
| 2023 Q3 | 1.25 Billion USD | -5.85% |
| 2023 Q1 | 1.6 Billion USD | -5.67% |
| 2022 Q2 | 1.8 Billion USD | 0.25% |
| 2022 Q3 | 1.57 Billion USD | -12.62% |
| 2022 Q4 | 1.7 Billion USD | 8.2% |
| 2022 FY | 1.7 Billion USD | -11.99% |
| 2022 Q1 | 1.79 Billion USD | -7.14% |
| 2021 Q2 | 2.05 Billion USD | -2.52% |
| 2021 Q3 | 2 Billion USD | -2.49% |
| 2021 Q1 | 2.11 Billion USD | -4.36% |
| 2021 FY | 1.93 Billion USD | -12.24% |
| 2021 Q4 | 1.93 Billion USD | -3.45% |
| 2020 Q1 | 1.54 Billion USD | -4.82% |
| 2020 Q4 | 2.2 Billion USD | 1.25% |
| 2020 Q3 | 2.18 Billion USD | 47.7% |
| 2020 Q2 | 1.47 Billion USD | -4.46% |
| 2020 FY | 2.2 Billion USD | 36.0% |
| 2019 Q4 | 1.62 Billion USD | -1.08% |
| 2019 Q2 | 1.29 Billion USD | 0.6% |
| 2019 Q3 | 1.64 Billion USD | 27.09% |
| 2019 Q1 | 1.28 Billion USD | 14.71% |
| 2019 FY | 1.62 Billion USD | 45.08% |
| 2018 FY | 1.11 Billion USD | 185.77% |
| 2018 Q3 | 1.02 Billion USD | 100.99% |
| 2018 Q2 | 511.77 Million USD | 34.89% |
| 2018 Q1 | 379.41 Million USD | -3.13% |
| 2018 Q4 | 1.11 Billion USD | 8.81% |
| 2017 Q2 | 383.07 Million USD | 54.07% |
| 2017 Q4 | 391.65 Million USD | 6.51% |
| 2017 FY | 391.65 Million USD | 45.41% |
| 2017 Q1 | 248.64 Million USD | -7.69% |
| 2017 Q3 | 367.72 Million USD | -4.01% |
| 2016 Q1 | 335.23 Million USD | -8.91% |
| 2016 FY | 269.34 Million USD | -26.82% |
| 2016 Q4 | 269.34 Million USD | -6.53% |
| 2016 Q3 | 288.17 Million USD | -5.69% |
| 2016 Q2 | 305.56 Million USD | -8.85% |
| 2015 FY | 368.04 Million USD | 10.45% |
| 2015 Q4 | 368.04 Million USD | -7.08% |
| 2015 Q3 | 396.1 Million USD | 44.66% |
| 2015 Q2 | 273.82 Million USD | -8.58% |
| 2015 Q1 | 299.52 Million USD | -10.11% |
| 2014 Q4 | 333.21 Million USD | 50.92% |
| 2014 FY | 333.21 Million USD | 119.36% |
| 2014 Q1 | 255.84 Million USD | 68.42% |
| 2014 Q3 | 220.79 Million USD | -7.06% |
| 2014 Q2 | 237.55 Million USD | -7.15% |
| 2013 Q3 | 167.24 Million USD | -4.69% |
| 2013 Q4 | 151.9 Million USD | -9.17% |
| 2013 FY | 151.9 Million USD | 1062.02% |
| 2013 Q1 | 64.4 Million USD | 392.69% |
| 2013 Q2 | 175.46 Million USD | 172.44% |
| 2012 FY | 13.07 Million USD | -70.39% |
| 2012 Q4 | 13.07 Million USD | 0.0% |
| 2011 FY | 44.14 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -27.894% |
| Alkermes plc | 2.13 Billion USD | 10.909% |
| Agenus Inc. | 313.91 Million USD | -506.277% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 50.307% |
| Aptorum Group Limited | 20.64 Million USD | -9120.798% |
| Ardelyx, Inc. | 297.57 Million USD | -539.555% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -148.602% |
| Bicycle Therapeutics plc | 595.34 Million USD | -219.678% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -2482.265% |
| ChromaDex Corporation | 54.96 Million USD | -3362.596% |
| Chimerix, Inc. | 212.77 Million USD | -794.461% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -6631.588% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -331.592% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 14.639% |
| Precision BioSciences, Inc. | 159.78 Million USD | -1091.118% |
| Dyadic International, Inc. | 8.21 Million USD | -23055.206% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -5896.159% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1036.051% |
| Lantern Pharma Inc. | 43.64 Million USD | -4260.332% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -1079.631% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -13019.372% |
| Incyte Corporation | 6.78 Billion USD | 71.938% |
| IO Biotech, Inc. | 150.71 Million USD | -1162.743% |
| Jaguar Health, Inc. | 50.76 Million USD | -3649.15% |
| Novavax, Inc. | 1.85 Billion USD | -2.578% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -400.301% |
| Opthea Limited | 188.79 Million USD | -908.088% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -128.456% |
| ContextLogic Inc. | 423 Million USD | -349.925% |
| MiMedx Group, Inc. | 239.04 Million USD | -696.153% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -995.507% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -36714.141% |
| NextCure, Inc. | 129.41 Million USD | -1370.569% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -3427.806% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -5081.685% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -5792.019% |
| Vaxcyte, Inc. | 1.4 Billion USD | -35.177% |
| PDS Biotechnology Corporation | 59.39 Million USD | -3104.544% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -197.118% |
| Pharming Group N.V. | 462.85 Million USD | -311.184% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -4820.323% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -202.787% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -9957.143% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -9957.143% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -1051.21% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -4102.489% |
| Acelyrin, Inc. | 742.69 Million USD | -156.255% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -28795.079% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -29623.27% |
| Summit Therapeutics Inc. | 202.94 Million USD | -837.763% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -2458.933% |
| Senti Biosciences, Inc. | 119.48 Million USD | -1492.833% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -733.478% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -1031.674% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -22932.567% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -39767.48% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -305.629% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -1439.13% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -592.194% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -302.5% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -18734.052% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -787.239% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -168001.919% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -359.881% |
| Immix Biopharma, Inc. | 19.92 Million USD | -9451.647% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -414.338% |
| MEI Pharma, Inc. | 41.37 Million USD | -4499.833% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -5772.928% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -458.448% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -1523.528% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1036.051% |
| Precigen, Inc. | 151.04 Million USD | -1160.026% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -5494.629% |
| AlloVir, Inc. | 190.79 Million USD | -897.495% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -405.559% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -275.961% |
| ImmuCell Corporation | 43.8 Million USD | -4244.358% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -193.106% |
| Onconetix, Inc. | 88.82 Million USD | -2042.704% |
| PureTech Health plc | 693.97 Million USD | -174.244% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -1848.284% |
| Elevation Oncology, Inc. | 89.09 Million USD | -2036.221% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -30586.569% |
| Seer, Inc. | 436.26 Million USD | -336.24% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -2232.415% |
| Innoviva, Inc. | 1.24 Billion USD | -53.049% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1337.198% |
| ESSA Pharma Inc. | 149.12 Million USD | -1176.257% |
| GlycoMimetics, Inc. | 45.31 Million USD | -4099.755% |
| GT Biopharma, Inc. | 14.1 Million USD | -13389.128% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -518.131% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -687.405% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -303.296% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -3654.031% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -1898.888% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -301232.673% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -236.049% |
| Aptose Biosciences Inc. | 12.92 Million USD | -14627.603% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -8506.116% |
| Soligenix, Inc. | 9.79 Million USD | -19325.515% |
| Century Therapeutics, Inc. | 360.69 Million USD | -427.649% |
| Kura Oncology, Inc. | 448.93 Million USD | -323.932% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -599.316% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -10904.227% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -1615.948% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -827.698% |
| Autolus Therapeutics plc | 375.38 Million USD | -407.0% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -656.323% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -435.83% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -3773.608% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -187.866% |
| GRI Bio, Inc. | 2.95 Million USD | -64283.66% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -17845.69% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -1016.137% |
| IGM Biosciences, Inc. | 423.41 Million USD | -349.488% |
| INmune Bio, Inc. | 57 Million USD | -3238.855% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -755.339% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2167.277% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -7187.174% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -27549.674% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -2429.951% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -1192.413% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -1049.931% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -202.282% |
| Verastem, Inc. | 149.71 Million USD | -1171.177% |
| Abeona Therapeutics Inc. | 64 Million USD | -2873.627% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -271.603% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -1132.175% |
| Histogen Inc. | 19.07 Million USD | -9878.404% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -8302.501% |
| Surrozen, Inc. | 46.08 Million USD | -4030.167% |
| Organovo Holdings, Inc. | 6.34 Million USD | -29876.075% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -44071.475% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -1221.408% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -16025.919% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -2428.539% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -22239.772% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -424.337% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -10418.068% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -343.217% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -14990.574% |
| Apollomics, Inc. | 55.38 Million USD | -3336.151% |
| Amarin Corporation plc | 831.68 Million USD | -128.835% |
| Mesoblast Limited | 669.15 Million USD | -184.416% |
| Turnstone Biologics Corp. | 112.81 Million USD | -1586.993% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -230.552% |
| Synaptogenix, Inc. | 31.11 Million USD | -6016.865% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -15520.33% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -247.257% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -32309.68% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -25810.685% |
| Exelixis, Inc. | 2.94 Billion USD | 35.318% |
| Better Therapeutics, Inc. | 22.94 Million USD | -8195.258% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -422.079% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -141.297% |
| NLS Pharmaceutics AG | 1.84 Million USD | -102961.775% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -23753.469% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -12851.215% |
| Gritstone bio, Inc. | 177.76 Million USD | -970.592% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1895.367% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -10554.754% |
| Avid Bioservices, Inc. | 336.55 Million USD | -465.485% |
| Insmed Incorporated | 1.32 Billion USD | -43.114% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -19666.44% |
| MediWound Ltd. | 66.45 Million USD | -2763.692% |
| OmniAb, Inc. | 401.98 Million USD | -373.446% |
| Alector, Inc. | 621.82 Million USD | -206.063% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -430.725% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -35288.267% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -3257.054% |
| Zai Lab Limited | 1.03 Billion USD | -83.652% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -297.777% |
| Aura Biosciences, Inc. | 255.07 Million USD | -646.126% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -153.748% |
| Immunic, Inc. | 54.29 Million USD | -3405.002% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -614.88% |
| Veracyte, Inc. | 1.13 Billion USD | -67.265% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -15997.573% |
| FibroGen, Inc. | 423.52 Million USD | -349.363% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -54075.377% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -40080.277% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -34952.744% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 83.296% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -21514.776% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -267.797% |
| TG Therapeutics, Inc. | 329.58 Million USD | -477.444% |
| Galecto, Inc. | 38.22 Million USD | -4878.63% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -6536.843% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 56.321% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -708.474% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -7561.142% |
| XBiotech Inc. | 227.24 Million USD | -737.509% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1895.367% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -1234.629% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -565.643% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1388.383% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -398.216% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -27.643% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -421.645% |
| Vaxxinity, Inc. | 44.35 Million USD | -4190.986% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -268.149% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -10127.025% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -523.891% |
| NexImmune, Inc. | 8.59 Million USD | -22045.593% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -17661.524% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -11011.914% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 94.247% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -8491.801% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -485077.367% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -998.016% |
| Ainos, Inc. | 31.84 Million USD | -5876.989% |
| Pluri Inc. | 39.52 Million USD | -4714.889% |
| Prothena Corporation plc | 696.38 Million USD | -173.296% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -573.416% |
| Celularity Inc. | 143.88 Million USD | -1222.673% |
| Rallybio Corporation | 115.62 Million USD | -1546.066% |
| Cue Biopharma, Inc. | 61.53 Million USD | -2993.094% |
| MeiraGTx Holdings plc | 458.16 Million USD | -315.389% |
| Omeros Corporation | 378.26 Million USD | -403.129% |
| Humacyte, Inc. | 128.22 Million USD | -1384.274% |
| Immunocore Holdings plc | 597 Million USD | -218.79% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -5988.426% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -2677.15% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -81.385% |
| CalciMedica, Inc. | 12.18 Million USD | -15519.048% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -650.318% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -1013.57% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -511.886% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -236.668% |
| Pulmatrix, Inc. | 33.95 Million USD | -5504.514% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -6910.908% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -1251.134% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -46.289% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1361.86% |
| Cytokinetics, Incorporated | 824.31 Million USD | -130.88% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -8909.994% |
| Nutriband Inc. | 7.51 Million USD | -25217.84% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -2310.493% |
| Vor Biopharma Inc. | 209.82 Million USD | -807.02% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 73.649% |
| Evogene Ltd. | 51.1 Million USD | -3624.352% |
| ProKidney Corp. | 420.55 Million USD | -352.544% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -3370.868% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -19890.813% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -248.326% |
| CorMedix Inc. | 82.05 Million USD | -2219.257% |
| BioLineRx Ltd. | 63.92 Million USD | -2877.209% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -372.761% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -6648.869% |
| Atai Life Sciences N.V. | 293.47 Million USD | -548.492% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -1066.669% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1393.652% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -238.628% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -1867.743% |
| MediciNova, Inc. | 66.26 Million USD | -2771.86% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -2063.984% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -42549.604% |
| GeoVax Labs, Inc. | 9.28 Million USD | -20401.305% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -223.54% |
| Biomea Fusion, Inc. | 199.92 Million USD | -851.938% |
| Mereo BioPharma Group plc | 66.49 Million USD | -2761.969% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -292.331% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -210.531% |
| Absci Corporation | 234.48 Million USD | -711.66% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -25917.512% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -459.939% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -1052.87% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -261.6% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -585.354% |
| Allakos Inc. | 243.61 Million USD | -681.241% |
| Imunon, Inc. | 21.91 Million USD | -8583.16% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -638.543% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -206.215% |
| BioAtla, Inc. | 119.65 Million USD | -1490.517% |
| NLS Pharmaceutics AG | 1.84 Million USD | -102961.775% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -59005.0% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -196.06% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -1883.823% |
| XOMA Corporation | 234.3 Million USD | -712.28% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -760.253% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1412.334% |
| aTyr Pharma, Inc. | 122.06 Million USD | -1459.128% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -1136.611% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -227.981% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -288.068% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -1622.819% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -12455.986% |
| Akari Therapeutics, Plc | 4.35 Million USD | -43601.056% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -11070.651% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -9.803% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -61611.726% |
| UroGen Pharma Ltd. | 178.31 Million USD | -967.338% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -304.299% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -342374.29% |
| Orgenesis Inc. | 14.55 Million USD | -12978.484% |
| Entera Bio Ltd. | 11.76 Million USD | -16076.634% |
| GH Research PLC | 226.3 Million USD | -740.999% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -3379.689% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -1671.456% |
| Xencor, Inc. | 952.69 Million USD | -99.769% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -24350.629% |
| Replimune Group, Inc. | 487.72 Million USD | -290.218% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -23480.226% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -193.501% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -61611.726% |
| Portage Biotech Inc. | 7.77 Million USD | -24365.625% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -42549.604% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -587.205% |
| OncoCyte Corporation | 74.89 Million USD | -2441.234% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -93502.994% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -32789.207% |
| Purple Biotech Ltd. | 44.3 Million USD | -4195.926% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -5476.924% |
| scPharmaceuticals Inc. | 94.47 Million USD | -1914.396% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -10446.885% |
| HilleVax, Inc. | 344.43 Million USD | -452.553% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -59823.835% |
| Tharimmune, Inc. | 10.94 Million USD | -17286.376% |
| Genprex, Inc. | 10.67 Million USD | -17735.758% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -283.555% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -1877.29% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -78349.34% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -45589.784% |
| OKYO Pharma Limited | 1.54 Million USD | -123381.83% |
| Savara Inc. | 177.56 Million USD | -971.828% |
| Curis, Inc. | 77.28 Million USD | -2362.645% |
| Daré Bioscience, Inc. | 21.28 Million USD | -8842.589% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -2876.101% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -23436.743% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -9724.898% |
| BeiGene, Ltd. | 5.8 Billion USD | 67.216% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -15539.584% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 8.877% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -431.688% |
| Erasca, Inc. | 395.29 Million USD | -381.456% |
| bluebird bio, Inc. | 619.16 Million USD | -207.381% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -43920.786% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 72.182% |
| DBV Technologies S.A. | 182.98 Million USD | -940.069% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -43920.786% |
| Moderna, Inc. | 18.42 Billion USD | 89.671% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -10347.28% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -16326.558% |
| Molecular Templates, Inc. | 35.38 Million USD | -5278.801% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -1276.473% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -141.241% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -526.551% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -1730.932% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -308.735% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -507.197% |
| MacroGenics, Inc. | 306.82 Million USD | -520.292% |
| RenovoRx, Inc. | 1.46 Million USD | -129721.351% |
| Adicet Bio, Inc. | 207.29 Million USD | -818.103% |
| Prime Medicine, Inc. | 193.85 Million USD | -881.775% |
| Aditxt, Inc. | 44.57 Million USD | -4169.297% |
| Adagene Inc. | 115.72 Million USD | -1544.518% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -42627.891% |
| Quantum-Si incorporated | 298.25 Million USD | -538.116% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -27.949% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -24587.387% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -441.783% |
| SciSparc Ltd. | 11.18 Million USD | -16920.041% |
| Vericel Corporation | 353.65 Million USD | -438.143% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -15483.738% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -3244.746% |
| Generation Bio Co. | 374.75 Million USD | -407.843% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -647.324% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -1100.238% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -457.521% |
| Invivyd, Inc. | 229.18 Million USD | -730.427% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -125.501% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -15539.197% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -943.468% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -9218.356% |
| 2seventy bio, Inc. | 565.42 Million USD | -236.592% |
| ADMA Biologics, Inc. | 329.18 Million USD | -478.155% |
| Clene Inc. | 52.34 Million USD | -3536.119% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -3140.321% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1365.18% |
| GeoVax Labs, Inc. | 9.28 Million USD | -20401.305% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -191.14% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -1736.85% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1359.651% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -1850.939% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -2580.65% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -684.645% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 2.903% |
| Evaxion Biotech A/S | 12.88 Million USD | -14666.369% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -655.051% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -152.851% |
| Trevena, Inc. | 40.6 Million USD | -4587.061% |
| Surrozen, Inc. | 46.08 Million USD | -4030.167% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -742.649% |
| Cingulate Inc. | 3.49 Million USD | -54409.978% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -11344.952% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -2797.216% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -16187.905% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -608.775% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -154.111% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1411.757% |
| Clearmind Medicine Inc. | 4.32 Million USD | -43910.402% |
| Kronos Bio, Inc. | 213.27 Million USD | -792.343% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -1091.096% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -22131.839% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -416.481% |
| Statera Biopharma, Inc. | 21.16 Million USD | -8890.124% |
| ImmunityBio, Inc. | 504.45 Million USD | -277.277% |
| Korro Bio, Inc. | 221.66 Million USD | -758.592% |
| Kineta, Inc. | 10.28 Million USD | -18411.633% |
| BioVie Inc. | 25.2 Million USD | -7449.805% |
| Codexis, Inc. | 136.56 Million USD | -1293.649% |
| Celularity Inc. | 143.88 Million USD | -1222.673% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -199.547% |
| Celcuity Inc. | 191.21 Million USD | -895.287% |
| Virax Biolabs Group Limited | 5.48 Million USD | -34604.445% |
| Cibus, Inc. | 544.41 Million USD | -249.585% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1411.733% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -9163.926% |
| IN8bio, Inc. | 33.7 Million USD | -5545.914% |
| Kodiak Sciences Inc. | 479.37 Million USD | -297.015% |
| Annexon, Inc. | 297.67 Million USD | -539.351% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -1000.041% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -1284.444% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -8965.789% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 36.35% |
| Eyenovia, Inc. | 28.77 Million USD | -6513.003% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -725.575% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -26245.252% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -3023.758% |
| Arcellx, Inc. | 825.13 Million USD | -130.652% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -2231.273% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -311.699% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -6089.207% |
| Moolec Science SA | 24.05 Million USD | -7813.01% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -513.682% |
| Geron Corporation | 394.07 Million USD | -382.948% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -1771.184% |
| Royalty Pharma plc | 16.38 Billion USD | 88.382% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -219.88% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -27108.454% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -15723.821% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -741.892% |
| Humacyte, Inc. | 128.22 Million USD | -1384.274% |
| Structure Therapeutics Inc. | 482.01 Million USD | -294.837% |
| 89bio, Inc. | 596.26 Million USD | -219.182% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -654.775% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -102774.649% |
| Genelux Corporation | 27.89 Million USD | -6723.149% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -2028.766% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -729.529% |
| Notable Labs, Ltd. | 19.54 Million USD | -9639.425% |
| Liquidia Corporation | 120.43 Million USD | -1480.308% |
| Mustang Bio, Inc. | 17.74 Million USD | -10626.981% |
| Immunovant, Inc. | 666.71 Million USD | -185.458% |
| Quantum-Si incorporated | 298.25 Million USD | -538.116% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -1217.983% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -3413.997% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -984.149% |
| Acasti Pharma Inc. | 73.3 Million USD | -2496.427% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -41707.195% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -7187.174% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -97.262% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -36570.734% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -8254.247% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -3588.121% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -953.279% |
| PepGen Inc. | 143.05 Million USD | -1230.412% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -4879.933% |
| United Therapeutics Corporation | 7.16 Billion USD | 73.445% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -9820.151% |
| Solid Biosciences Inc. | 164.93 Million USD | -1053.87% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -32309.68% |
| Immuneering Corporation | 102.58 Million USD | -1755.232% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -44071.475% |
| Silo Pharma, Inc. | 7.74 Million USD | -24469.408% |
| Belite Bio, Inc | 94.64 Million USD | -1910.926% |
| XOMA Corporation | 234.3 Million USD | -712.28% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -716.157% |
| Bionomics Limited | 27.64 Million USD | -6783.34% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -374.131% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1672.247% |
| uniQure N.V. | 831.68 Million USD | -128.833% |
| Cassava Sciences, Inc. | 151.66 Million USD | -1154.875% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -42627.891% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -594.883% |
| Forte Biosciences, Inc. | 38.98 Million USD | -4782.455% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -46625.454% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -5067.335% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -26245.252% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -54075.377% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -16000.0% |
| Altimmune, Inc. | 210.64 Million USD | -803.523% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -144.663% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1672.247% |
| Compugen Ltd. | 121.33 Million USD | -1468.547% |
| Peak Bio, Inc. | 2.59 Million USD | -73200.339% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -1004.401% |
| Benitec Biopharma Inc. | 52.21 Million USD | -3545.242% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -456.715% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -5373.157% |
| Zura Bio Limited | 100.84 Million USD | -1787.271% |
| PolyPid Ltd. | 15.37 Million USD | -12280.829% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -1495.477% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -5373.157% |
| Instil Bio, Inc. | 325.63 Million USD | -484.461% |
| argenx SE | 4.54 Billion USD | 58.102% |
| Immunome, Inc. | 148.54 Million USD | -1181.258% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -1113.183% |
| Verona Pharma plc | 308.12 Million USD | -517.667% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -2088.596% |
| Shattuck Labs, Inc. | 159.56 Million USD | -1092.738% |
| CervoMed Inc. | 9.97 Million USD | -18984.252% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -909.881% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -16612.162% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -960.829% |
| Moolec Science SA | 24.05 Million USD | -7813.01% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -31010.539% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -1000.458% |
| AnaptysBio, Inc. | 452.38 Million USD | -320.696% |
| Design Therapeutics, Inc. | 289.64 Million USD | -557.078% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -2513.362% |
| NeurAxis, Inc. | 509.49 Thousand USD | -373440.426% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -35027.003% |
| Lumos Pharma, Inc. | 40.63 Million USD | -4583.255% |
| Achilles Therapeutics plc | 161.45 Million USD | -1078.761% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -2088.596% |
| 180 Life Sciences Corp. | 5.25 Million USD | -36085.753% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -2602.315% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -22131.839% |
| Nutriband Inc. | 7.51 Million USD | -25217.84% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -647.266% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -854.928% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -2397.22% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -3186.106% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -261.45% |
| Palisade Bio, Inc. | 14.05 Million USD | -13443.844% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -805.005% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -30.38% |
| Neurogene Inc. | 222.57 Million USD | -755.082% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -194.327% |
| AEON Biopharma, Inc. | 6.84 Million USD | -27703.959% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -320.095% |
| Sesen Bio, Inc. | 189.17 Million USD | -906.048% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -600.041% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -13779.806% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -143.888% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -612.818% |
| Athira Pharma, Inc. | 160.24 Million USD | -1087.67% |
| Vaccinex, Inc. | 3.63 Million USD | -52314.789% |
| HCW Biologics Inc. | 28.51 Million USD | -6574.629% |
| XOMA Corporation | 234.3 Million USD | -712.28% |
| Nektar Therapeutics | 398.03 Million USD | -378.147% |
| Arvinas, Inc. | 1.3 Billion USD | -45.882% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -11070.651% |
| Merus N.V. | 458.49 Million USD | -315.094% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -831.261% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -956.126% |
| Rezolute, Inc. | 132.73 Million USD | -1333.798% |
| Clene Inc. | 52.34 Million USD | -3536.119% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -12652.59% |
| BeyondSpring Inc. | 24.8 Million USD | -7571.642% |
| Synlogic, Inc. | 75.55 Million USD | -2419.101% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -15944.352% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -20224.445% |
| Peak Bio, Inc. | 2.59 Million USD | -73200.339% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -988.571% |
| Krystal Biotech, Inc. | 818.35 Million USD | -132.562% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -691.548% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -162.223% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -53103.479% |
| MannKind Corporation | 475.19 Million USD | -300.503% |
| Ikena Oncology, Inc. | 192.09 Million USD | -890.765% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -14130.455% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -1533.085% |
| Gossamer Bio, Inc. | 311.91 Million USD | -510.158% |
| CohBar, Inc. | 16.36 Million USD | -11529.107% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -5312.453% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -25917.512% |
| Legend Biotech Corporation | 1.84 Billion USD | -2.952% |
| Mural Oncology plc | 301.74 Million USD | -530.725% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -5997.008% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -33404.319% |
| Disc Medicine, Inc. | 367.99 Million USD | -417.174% |
| Champions Oncology, Inc. | 26.13 Million USD | -7182.952% |
| REGENXBIO Inc. | 573.97 Million USD | -231.582% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -70177.742% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -1132.742% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -15660.576% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -459.702% |
| Vaxart, Inc. | 91.83 Million USD | -1972.505% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -3077.058% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -1183.099% |
| Cellectis S.A. | 334.27 Million USD | -469.354% |
| Longeveron Inc. | 12.17 Million USD | -15528.026% |
| Repare Therapeutics Inc. | 253.9 Million USD | -649.576% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 41.702% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -847.578% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 8.877% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -117018.831% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -585.31% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -1066.894% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -1271.721% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -7357.021% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 91.627% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -64.932% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -15483.738% |
| Veru Inc. | 50.59 Million USD | -3661.53% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -4077.949% |
| Cingulate Inc. | 3.49 Million USD | -54409.978% |
| Passage Bio, Inc. | 150.54 Million USD | -1164.194% |
| Context Therapeutics Inc. | 16.06 Million USD | -11748.424% |
| Exicure, Inc. | 11.58 Million USD | -16335.069% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -406.101% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -1077.405% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -10792.748% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -471.964% |
| Nuvalent, Inc. | 732.38 Million USD | -159.861% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -12635.352% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -2025.177% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -13311.183% |
| OmniAb, Inc. | 401.98 Million USD | -373.446% |
| Anew Medical, Inc. | 19.45 Million USD | -9681.998% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -7020.936% |
| Lipocine Inc. | 23 Million USD | -8174.314% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -1261.292% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -522.84% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2167.277% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -1465.889% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -23884.638% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -115.712% |
| Ocugen, Inc. | 64.54 Million USD | -2848.52% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1428.156% |
| Q32 Bio Inc. | 306.11 Million USD | -521.713% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -45127.685% |
| Alumis Inc. Common Stock | 89.61 Million USD | -2023.801% |
| Equillium, Inc. | 50.53 Million USD | -3666.438% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -2430.994% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -4511.142% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -111795.678% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -7180.445% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -2853.37% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -50963.142% |
| Dominari Holdings Inc. | 57.55 Million USD | -3206.545% |
| Edesa Biotech, Inc. | 8.89 Million USD | -21307.058% |
| vTv Therapeutics Inc. | 11.01 Million USD | -17173.38% |
| Bio-Techne Corporation | 2.81 Billion USD | 32.348% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -103.089% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -134.541% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -585.423% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -4463.764% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -185.083% |
| Nkarta, Inc. | 378.88 Million USD | -402.311% |
| BioCardia, Inc. | 2.98 Million USD | -63615.467% |
| Iterum Therapeutics plc | 26.25 Million USD | -7147.728% |